Vanguard finally lashes up - with Elan

OXFORD - Vanguard Medica Group plc believes that it is getting a better deal for frovatriptan with its new partner Elan Corp. plc than it had with its original partner SmithKline Beecham plc, as well it might, since the anti-migraine compound is further along in development.

London investors, who had set their sights on more of a blockbuster deal with a big pharma name, may take more time to warm to the transaction...